Figure 1.
Serological screening of 2,430 serum samples from five African countries for antibodies against the Marburgvirus glycoprotein (MARV-GP). Close-up map of Central Africa with approximate location of relevant towns, cities and districts (A). Results of serum neutralization at 1:50 dilution of MARV-GP or Machupo virus glycoprotein (MACV-GP) pseudotyped HIV with samples from Uganda (C), Cameroon (D, F), Ghana (E), Republic of Congo (G), Kinshasa, DRC (H), Kasaï Oriental, DRC (I) and negative control samples from Kinshasa, DRC (J). Confirmatory ELISA results for detection of anti-MARV-GP antibodies in 51 neutralizing samples compared to 22 randomly selected non-neutralizing samples across all sample sets (B).